Unlocking virtual items in a virtual space responsive to physical token detection

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Disney Enterprises, Inc. patent solves the following problem:

Conventionally, various virtual objects in a virtual space can be obtained. Such access, however, will be mostly based on a stage or in the completion of the gameplay in the virtual space. For example, a videogame, a given virtual object can be accessed responsive to a user to attain a level of gameplay. Moreover, for a given character, in particular virtual things shall be limited to the virtual objects belonging to the given character.

Our analysis of this patent is as follows:

Disney Enterprises, Inc.’s patent US 9457263 B2 deals with Unlocking virtual items in a virtual space responsive to physical token detection.
Virtual goods can be unlocked in a virtual space responsive to the physical mark detection. A common virtual object repository can be given in virtual space. Once unlocked, in a given virtual object can be accessible to many characters in the virtual space by the virtual object repository. Dry in a virtual space can be held. customization can be based on virtual goods accessible by the virtual object repository.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Modality with multicomputer system and powering sequence therefor

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Virtual Imaging, Inc. patent solves the following problem:

Health information technology (health IT) makes it possible to efficiently manage patient care through secure use and sharing of electronic health records (EHRs). EHRs include electronic medical records (EMRs) and other critical data created and regularly consulted and updated healthcare organizations and their staff. An electronic medical record (EMR) standard includes all of the medical history of a patient from a healthcare provider. EMR records used by healthcare providers, such as hospitals, clinics, medical specialist, and the like to identify patients, track patients' healthcare overtime, check or update patient health parameters, monitor and improve the overall quality of care. So it is generally necessary to refer to the EMR in a patient every time a patient seeks care from a healthcare provider. In the end, the healthcare organizations that seek to implement an EMR infrastructure accessible from many points of care. The healthcare industry has developed dedicated EMR software applications and dedicated communication protocol that allows for an easy flow of medical data.

Our analysis of this patent is as follows:

Virtual Imaging, Inc.’s patent US 9456799 B2 deals with Modality with multicomputer system and powering sequence therefor.
An imaging modality includes a first computer, a second computer, a computer selected circuit connected to a manually operable switch and configured to allow an operator to choose whether to operate first computer or the second computer by manual operation of manually operable switch, a power supply unit configured to supply operating power to the first computer and a second computer; and a power control circuit connected to a power input of the computer and connected to a power input to the second computer. The power control circuit to cause a signal to activate or deactivate flow of power supply to the second computer in response to the first computer receiving a turn or turn OFF input.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Highly concentrated aqueous protein solution with reduced viscosity

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Adocia patent solves the following problem:

Our analysis of this patent is as follows:

Adocia’s patent US 9457089 B2 deals with Highly concentrated aqueous protein solution with reduced viscosity.
In an aqueous solution, a composition includes at least one protein, including at least one antibody fragments, and at least one water-soluble viscosity-reducing agent selected from the group consisting of cytidine, 2-deoxycytidine, uridine, 2-deoxyuridine, thymidine and ribothymidine, alone or as a mixture. proteins include at least one antibody fragment in a concentration greater than or equal to 50 mg / ml.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Acoustophoretic device with piezoelectric transducer array

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Flodesign Sonics, Inc. patent solves the following problem:

The ability to separate a particle / fluid mixture into its separate components is desirable in many applications. Acoustophoresis is the separation of particles using high intensity sound waves, and without the use of membranes or physical size exclusion filtering. It is known that the high intensity standing sound waves can exert forces on particles in a fluid when there is a differential in both density and / or compressibility, known locally as the acoustic differences matter. The profile of the pressure of a standing wave comprising the areas of local minimum pressure the magnitude of the nodes and the local maxima of his anti-nodes. Depending on the density and compressibility of the particles, they are trapped in the nodes or anti-nodes of the standing wave. The higher the frequency the standing wave, the smaller the particles to be trapped by the pressure of the standing wave.

Our analysis of this patent is as follows:

Flodesign Sonics, Inc.’s patent US 9457302 B2 deals with Acoustophoretic device with piezoelectric transducer array.
An apparatus for separating particles from a fluid stream includes a course to the extent that there is at least one inlet and at least one outlet. At least one ultrasonic transducer located in a wall of the flow chamber. transducer includes a piezoelectric war with at least two piezoelectric elements. The piezoelectric forest includes a piezoelectric material to create a multi-dimensional acoustic standing wave in the flow chamber. A reflector located on the wall on the other side of the flow chamber from at least one ultrasonic transducer.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Regulated vacuum off-gassing of gas filter for fluid processing system and related methods

File for Quick & Easy Patent Protection with PowerPatent.

The Life Technologies Corporation patent solves the following problem:

The present invention relates to fluid processing systems and related gas filtering systems that use a partial vacuum in a lower part of the gas filter.

Our analysis of this patent is as follows:

Life Technologies Corporation’s patent US 9457306 B2 deals with Regulated vacuum off-gassing of gas filter for fluid processing system and related methods.
A method for filtering a gas sparging includes a gas through a liquid in one chamber of a vessel. In one embodiment of the vessel may comprise a flexible bag. The sparged gas passed from the vessel by a gas filter with a filter assembly. A partial vacuum is applied to the gas filter so that the partial vacuum assists in drawing the gas through the gas filter.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

PEGylation by the dock and lock (DNL) technique

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The Ibc Pharmaceuticals, Inc. patent solves the following problem:

The effectiveness of a therapeutic agent may be enhanced by improving its bioavailability in some ways, one of which is the PEGylation, a process of chemically linking polyethylene glycol (PEG) to therapeutic agents of interest, with the conjugate results showed an increased serum half-life. Additional advantages of pegylated products that also include low immunogenicity, reduced dosing frequency, increased solubility, enhanced durability, and reduced renal clearance. Because the most common reactive sites on the protein (including peptide) for attaching PEG is the amino groups of lysine and the amino group of the A-terminal residue, the first method of PEGylation resulted in changes many places, yielding not only monoPEGylated conjugates consisting of mixtures of isomers seats, as PEGINTRON (Grace et al, J. Biol Chem 2005; 280: 6327) and PEGASYS (Dhalluin et al, Bioconjugate Chem 2005; 16: 504), but also adducts containing more than one PEG chain. Site-specific attachment of a PEG amino group of A-terminal residue reported that the predominant reaction products PEG-aldehyde (PEG-ALD) to lower pH of the IFN-1b (Basu et al., Bioconjugate Chem. 2006, 17: 618) or IFN-1a (Pepinsky et al, J. Pharmacol exp Father 2001; 297: …. 1059). Similar methods were applied in preparing N-ill relative PEG to G-CSF (Kinstler et al, Pharm Res 1996; 13: 996) or the soluble tumor necrosis things receptor (Kerwin et al Protein Sci 2002; 11: 1825). More recently, a strong-phase process for PEGylation A-terminus artificial interferon alpha-2a reported (Lee et al., Bioconjug. Chem. Oct. 18, 2007, ePub).

Our analysis of this patent is as follows:

Ibc Pharmaceuticals, Inc.’s patent US 9457100 B2 deals with PEGylation by the dock and lock (DNL) technique.
The present invention concerns methods and compositions for forming pegylated complexes of defined stoichiometry and structure. In preferred embodiments, the pegylated complex formed using dock-and-lock technology, by attaching a target agent to a DDD file and pasting a PEG moiety to an AD and authority DDD sequence to bind to AD in a 2: 1 stoichiometry, to form pegylated complexes with two target agents and one PEG moiety. In alternative embodiments, the target agent can be included in the AD and the PEG to the DDD to form pegylated complexes with two PEG moieties and one target agent. In more preferred embodiments, the target agent may comprise any peptide or protein of physiologic or therapeutic activities. The pegylated complexes exhibit a significantly slower rate of clearance when injected into a subject and the use for the treatment of a wide variety of diseases.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Anti-BAFFR antibody formulations

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The Novartis Pharma Ag patent solves the following problem:

BAFFR: BAFF pattern is critically involved in the maturation of the transitional B-cells, for the salvation and the activation of mature B-cells, and for the isotype class switch in response to T cell-dependent antigens. BAFF and receptor BAFFR important for the survival and growth of malignant B-cells. Furthermore, BAFFR usually not expressed in pre-B cells, but recently shown to express human ALL (B-lineage acute lymphoblastic leukemia) cells (Parameswaran, 2010, Cancer Res. 70 (11) 4346-4356 ). The removal of autoreactive B cells and the blockade should not live / activation mediated by excess BAFF levels in patients suffering from autoimmune disorders or cancer represents a well-validated therapeutic target . Thus, an anti-BAFFR antibody, in particular an antibody capable of antibody-dependent cell-mediated cytotoxicity (ADCC) and blockade of ligand binding BAFFR offer an effective therapeutic agent for autoimmune diseases and B cell neoplasms.

Our analysis of this patent is as follows:

Novartis Pharma Ag’s patent US 9458240 B2 deals with Anti-BAFFR antibody formulations.
Anti-BAFFR antibody formulated as lyophilisate or liquid formulation. The lyophilisates can be reconstituted to give a solution with a high concentration of antibody active components for delivery to a patient without high levels of antibody aggregation. lyophilisate can be reconstituted with an aqueous reconstituent to provide an aqueous composition wherein the antibody has a concentration of at least 50 mg / ml. The lyophilisate or liquid pharmaceutical composition may include one or more of a sugar, a buffering agent, a surfactant, and / or a free amino acid.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Enriching contact data based on content sharing history in a content management system

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Dropbox, Inc. patent solves the following problem:

Contact lists used to store contact information for individuals and businesses. Users often add a new contact to their contact list when they were introduced to another person or to meet other people in certain social contexts. In many cases, the information for a contact in the contact list is not complete. For example, a contact may include a person's first name and phone number, but less than last names, email address, business address, or fax number.

Our analysis of this patent is as follows:

Dropbox, Inc.’s patent US 9460210 B2 deals with Enriching contact data based on content sharing history in a content management system.
A system for managing improve contact records obtained from a client device to use to record the user stored in the system management. The system for managing records receive contact from a client device authorized to use the system in the direction. The system management in comparing records of contacts with the user profile stored in the system management. The system in direct contact record matches with the user profile of user accounts at least a share occurred between user accounts and user account on the client device is authorized. The system management in identifying a profile matching user corresponding to the contact record. The system in the management information determines changes to the contact record based on user profile matching.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Nucleic acid encoding chimeric IL-1 receptor type I antagonists

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Eleven Biotherapeutics, Inc. patent solves the following problem:

Interleukin-1 alpha (IL-1) and beta (IL-1) is the prototypic member of a family of immunoregulatory cytokines and have few prominent role in controlling the immune system. IL-1 and IL-1 binds to interleukin-1 receptor (IL-1RI), into engagement with the secondary receptor, interleukin-1 receptor accessory protein (IL-1RAcP). Marking impatient to IL-1 and IL-1 leads to Amplified T cell responses, including proliferation and survival temple in T cells and the development of TH17 cells.

Our analysis of this patent is as follows:

Eleven Biotherapeutics, Inc.’s patent US 9458216 B2 deals with Nucleic acid encoding chimeric IL-1 receptor type I antagonists.
Featured in the non-naturally occurring cytokine heritage can be used, inter alia, changing the cellular signal responsive to interleukin-1 receptor (IL-1RI), to treat the disease, and to detect and / or bind the cellular receptor, as well as other agents. Exemplary cytokine domains contain amino acid residues from at least two parents cytokines inheritance, for example, receptor binding part, face to face, fibers, and loops from at least two parents cytokines inheritance.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Electronic device, information processing apparatus, information processing method, and program

File for Quick & Easy Patent Protection with PowerPatent.

The Panasonic Intellectual Property Management Co., Ltd. patent solves the following problem:

The present disclosure relates to an electronic device and an information processing system. More particularly, the present disclosure relates to an information processing system in which a user manipulations done by using an electronic device as a manipulation input device, for example, a controller.

Our analysis of this patent is as follows:

Panasonic Intellectual Property Management Co., Ltd.’s patent US 9459221 B2 deals with Electronic device, information processing apparatus, information processing method, and program.
An exemplary electronic device is a housing lying in two hands, and measures the potential of first and second fingers of each different hands. device includes: a first electrode group which in a position to come in contact with the first finger, including a first main electrode and at least a first auxiliary electrode given a position from the first electrode; a second electrode group which in a position to come in contact with the second finger, including a second main electrode and at least a second auxiliary electrode in a given position from the second main electrode; a biological signal processor for, from the potential values ​​measured in the first and second electrode groups, determine individual contacts said about the first and second fingers; and a transmission circuit for presenting information about a finger contact state based on a result of determination.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.